Neolitsea sericea essential oil attenuates LPS-induced inflammation in RAW 264.7 macrophages by suppressing NF-κB and MAPK activation

Natural Product Communications

Volumn 5, Issue 8, 2010, Pages 1311-1316

  Yoon, Weon Jong ^a   Moon, Ji Young ^a   Kang, Ji Yong ^a   Kim, Gi Ok ^a   Lee, Nam Ho ^b   Hyun, Chang Gu ^a  

^a Jeju Hi Tech Industry Development Institute   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Chemical composition; Essential oil; Inflammation; Neolitsea sericea; Nuclear factor B

Indexed keywords

CARYOPHYLLENE; CYCLOOXYGENASE 2; CYTOKINE; ESSENTIAL OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NEOLITSEA SERICEA ESSENTIAL OIL; NITRIC OXIDE; OCIMENE; PROSTAGLANDIN E2; SABINENE; TERPINEN 4 OL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; LIPOPOLYSACCHARIDE;

ANGIOSPERM; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; INFLAMMATION; MACROPHAGE; MOUSE; NEOLITSEA SERICEA; NONHUMAN; PLANT LEAF; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; LAURACEAE;

NEOLITSEA SERICEA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DINOPROSTONE; INTERLEUKIN-6; LAURACEAE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; OILS, VOLATILE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956693903     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1000500835     Document Type: Article

References (24)

1. Wang ZS, An SQ, Liu H, Leng X, Zheng JW, Liu YH. (2005) Genetic structure of the endangered plant Neolitsea sericea (Lauraceae) from the Zhoushan archipelago using RAPD markers. Annals of Botany, 95, 305-313.
2. Kim JY, Oh TH, Kim BJ, Kim SS, Lee NH, Hyun CG. (2008) Chemical composition and anti-inflammatory effects of essential oil from Farfugium japonicum flower. Journal of Oleo Science, 57, 623-628.
3. Reichling J, Schnitzler P, Suschke U, Saller R. (2009) Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties - an overview. Forschende Komplementärmedizin, 16, 79-90.
4. Yoon WJ, Kim SS, Oh TH, Lee NH, Hyun CG (2009) Abies koreana essential oil inhibits drug-resistant skin pathogen growth and LPS-induced inflammatory effects of murine macrophage. Lipids, 44, 471-476.
5. Maggi F, Bramucci M, Cecchini C, Coman MM, Cresci A, Cristalli G, Lupidi G, Papa F, Quassinti L, Sagratini G, Vittori S. (2009) Composition and biological activity of essential oil of Achillea ligustica All. (Asteraceae) naturalized in central Italy: ideal candidate for anti-carcinogenic formulations. Fitoterapia, 80, 313-319.
6. Yoon WJ, Moon JY, Song G, Lee YK, Han MS, Lee JS, Ihm BS, Lee WJ, Lee NH, Hyun CG. (2010) Artemisia fukudo essential oil attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Food and Chemical Toxicology, 48, 1222-1229.
7. Kim JY, Kim SS, Oh TH, Baik JS, Song G, Lee NH, Hyun CG. (2009) Chemical composition, antioxidant, anti-elastase, and antiinflammatory activities of Illicium anisatum essential oil. Acta Pharmaceutica, 59, 289-300.
8. Yoon WJ, Kim SS, Oh TH, Lee NH, Hyun CG. (2009) Cryptomeria japonica essential oil inhibits the growth of drug-resistant skin pathogens and LPS-induced nitric oxide and pro-inflammatory cytokine production. Polish Journal of Microbiology, 58, 61-68.
9. Murakami A, Ohigashi H. (2007) Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. International Journal of Cancer, 121, 2357-2363.
10. Sugita T. (2009) Targeting therapy for inflammatory diseases by anti-TNFalpha biologics. Yakugaku Zasshi, 129, 19-24.
11. Ding C, Cicuttini F, Li J, Jones G. (2009) Targeting IL-6 in the treatment of inflammatory and autoimmune diseases. Expert Opinion on Investigational Drugs, 18, 1457-1466.
12. Kim JH, Bachmann RA, Chen J. (2009) Interleukin-6 and insulin resistance. Vitamins and Hormones, 80, 613-633.
13. Fogal B, Hewett SJ. (2008) Interleukin-1beta: a bridge between inflammation and excitotoxicity? Journal of Neurochemistry, 106, 1-23.
14. Ren K, Torres R. (2008) Role of interleukin-1beta during pain and inflammation. Brain Research Reviews, 60, 57-64.
15. Kim EY, Moudgil KD. (2008) Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunology Letters, 120, 1-5.
16. Feldmann M. (2008) Many cytokines are very useful therapeutic targets in disease. Journal of Clinical Investigation, 118, 3533-3536.
17. Ghosh S, Hayden MS. (2008) New regulators of NF-kappaB in inflammation. Nature Reviews Immunology, 8, 837-848.
18. Wong ET, Tergaonkar V. (2009) Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clinical Science, 116, 451-465.
19. Edwards MR, Bartlett NW, Clarke D, Birrell M, Belvisi M, Johnston SL. (2009) Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacology and Therapeutics, 121, 1-13.
20. Malemud CJ, Miller AH. (2008) Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opinion on Therapeutic Targets, 12, 171-183.
21. Ji RR, Gereau RW 4th, Malcangio M, Strichartz GR. (2009) MAP kinase and pain. "MAP kinase and pain," Brain Research Reviews, 60, 135-148.
22. Brown MD, Sacks DB. (2008) Compartmentalised MAPK pathways. Handbook of Experimental Pharmacology, 186, 205-235.
23. Hevel JM, Marletta MA. (1997) Nitric-oxide synthase assay. Methods in Enzymology, 233, 250-258.
24. Bradford MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.